뉴스

• D&D Pharmatech tumbles 18% after Pfizer halts ORALINK candidate [K-bio pulse] sharply after it was confirmed that development had been halted on an obesity drug candidate built with Coming on the heels of questions about ... www.edaily.co.kr · 2026.08.06